Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus Infections
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus Infections
Creator
Sinzger, Christian
Boukhallouk, Fatima
Florin, Luise
Fritzen, Anna
Hochdorfer, Daniel
Lieber, Diana
Mikuličić, Snježana
Schwickert, Jonas
Suarez, Henar
Yáñez-Mó, María
Fast, Laura
Monk, Peter
source
PMC
abstract
Tetraspanins are suggested to regulate the composition of cell membrane components and control intracellular transport, which leaves them vulnerable to utilization by pathogens such as human papillomaviruses (HPV) and cytomegaloviruses (HCMV) to facilitate host cell entry and subsequent infection. In this study, by means of cellular depletion, the cluster of differentiation (CD) tetraspanins CD9, CD63, and CD151 were found to reduce HPV16 infection in HeLa cells by 50 to 80%. Moreover, we tested recombinant proteins or peptides of specific tetraspanin domains on their effect on the most oncogenic HPV type, HPV16, and HCMV. We found that the C-terminal tails of CD63 and CD151 significantly inhibited infections of both HPV16 and HCMV. Although CD9 was newly identified as a key cellular factor for HPV16 infection, the recombinant CD9 C-terminal peptide had no effect on infection. Based on the determined half-maximal inhibitory concentration (IC(50)), we classified CD63 and CD151 C-terminal peptides as moderate to potent inhibitors of HPV16 infection in HeLa and HaCaT cells, and in EA.hy926, HFF (human foreskin fibroblast) cells, and HEC-LTT (human endothelial cell-large T antigen and telomerase) cells for HCMV, respectively. These results indicate that HPV16 and HCMV share similar cellular requirements for their entry into host cells and reveal the necessity of the cytoplasmic CD151 and CD63 C-termini in virus infections. Furthermore, this highlights the suitability of these peptides for functional investigation of tetraspanin domains and as inhibitors of pathogen infections.
has issue date
2018-10-02
(
xsd:dateTime
)
bibo:doi
10.3390/ijms19103007
bibo:pmid
30279342
has license
cc-by
sha1sum (hex)
a43db4dbbe6272ff71bcd5dc9cbf29bad9cd958e
schema:url
https://doi.org/10.3390/ijms19103007
resource representing a document's title
Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus Infections
has PubMed Central identifier
PMC6212908
has PubMed identifier
30279342
schema:publication
Int J Mol Sci
resource representing a document's body
covid:a43db4dbbe6272ff71bcd5dc9cbf29bad9cd958e#body_text
is
schema:about
of
named entity 'CD63'
named entity 'infection'
named entity 'factor'
named entity 'infections'
named entity 'C-terminal'
named entity 'HPV'
named entity 'Inhibition'
named entity 'Cytomegalovirus'
named entity 'INHIBITION'
named entity 'PATHOGENS'
named entity 'TETRASPANIN'
named entity 'IDENTIFIED'
named entity 'SUBSEQUENT'
named entity 'LEAVES'
named entity 'MODERATE'
named entity 'ENDOTHELIAL CELL'
named entity 'CD9'
named entity 'CYTOPLASMIC'
named entity 'RECOMBINANT'
named entity 'THESE'
named entity 'CELLULAR'
named entity 'INHIBITORS'
named entity 'INFECTIONS'
named entity 'NEWLY'
named entity 'INFECTION'
named entity 'PEPTIDES'
named entity 'KEY'
named entity 'AS INHIBITORS'
named entity 'VULNERABLE'
named entity 'COMPONENTS'
named entity 'SIMILAR'
named entity 'CONCENTRATION'
named entity 'PATHOGEN'
named entity 'CYTOMEGALOVIRUS INFECTIONS'
named entity 'TETRASPANIN'
named entity 'CELLS'
named entity 'NO EFFECT'
named entity 'ENTRY'
named entity 'CD151'
named entity 'CELL MEMBRANE'
named entity '80%'
named entity 'NECESSITY'
named entity 'IMPAIRS'
named entity 'FUNCTIONS'
named entity 'FORESKIN FIBROBLAST'
named entity 'INTRACELLULAR TRANSPORT'
named entity 'DETERMINED'
named entity 'HELA'
named entity 'CLUSTER OF DIFFERENTIATION'
named entity 'TO REGULATE'
named entity 'HPV TYPE'
named entity 'STUDY'
named entity 'MEANS'
named entity 'RECOMBINANT PROTEINS'
named entity 'THEIR'
named entity 'HACAT'
named entity 'EFFECT'
named entity 'TAILS'
named entity 'TETRASPANINS'
named entity 'LARGE T ANTIGEN'
named entity 'TESTED'
named entity 'ENTRY INTO HOST'
named entity 'FACTOR'
named entity 'TELOMERASE'
named entity 'COMPOSITION'
named entity 'RESULTS'
named entity 'CLASSIFIED'
named entity 'HCMV'
named entity 'SHARE'
named entity 'HPV16 INFECTION'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 14
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software